AcelRx Pharmaceuticals Current Ratio 2009-2020 | ACRX

AcelRx Pharmaceuticals current ratio from 2009 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
AcelRx Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-03-31 $0.06B $0.02B 3.69
2019-12-31 $0.07B $0.01B 5.27
2019-09-30 $0.09B $0.01B 7.49
2019-06-30 $0.10B $0.01B 11.69
2019-03-31 $0.10B $0.02B 5.03
2018-12-31 $0.11B $0.02B 6.78
2018-09-30 $0.07B $0.01B 4.56
2018-06-30 $0.05B $0.01B 4.01
2018-03-31 $0.05B $0.01B 4.05
2017-12-31 $0.06B $0.01B 4.64
2017-09-30 $0.07B $0.02B 4.78
2017-06-30 $0.07B $0.01B 4.92
2017-03-31 $0.08B $0.01B 6.11
2016-12-31 $0.09B $0.01B 8.74
2016-09-30 $0.10B $0.02B 6.24
2016-06-30 $0.11B $0.02B 5.02
2016-03-31 $0.11B $0.02B 6.71
2015-12-31 $0.12B $0.01B 9.31
2015-09-30 $0.12B $0.01B 15.55
2015-06-30 $0.05B $0.01B 4.02
2015-03-31 $0.07B $0.02B 4.26
2014-12-31 $0.08B $0.01B 5.56
2014-09-30 $0.09B $0.01B 8.36
2014-06-30 $0.09B $0.01B 10.67
2014-03-31 $0.09B $0.01B 20.39
2013-12-31 $0.11B $0.01B 15.22
2013-09-30 $0.08B $0.01B 6.20
2013-06-30 $0.04B $0.01B 2.91
2013-03-31 $0.05B $0.02B 3.36
2012-12-31 $0.06B $0.01B 4.31
2012-09-30 $0.03B $0.01B 2.07
2012-06-30 $0.03B $0.01B 3.15
2012-03-31 $0.03B $0.01B 3.47
2011-12-31 $0.04B $0.01B 4.86
2011-09-30 $0.03B $0.01B 6.69
2011-06-30 $0.04B $0.00B 10.33
2011-03-31 $0.04B $0.01B 6.38
2010-12-31 $0.01B $0.01B 0.43
2010-09-30 $0.00B 0.00
2010-06-30 $0.00B 0.00
2010-03-31 $0.00B 0.00
2009-12-31 $0.01B $0.01B 2.15
2008-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.090B $0.002B
AcelRx Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of pain. The Company product candidates comprises: ARX-01 or the Sufentanil NanoTab PCA System; ARX-02 or the Sufentanil NanoTab BTP Management System; and ARX-03 or the Sufentanil/Triazolam NanoTab which are in their development stage. Its product ARX-01 is focused on acute post-operative pain, ARX-02 is focused on the treatment of cancer breakthrough pain and ARX-03 is focused on providing mild sedation, anxiety reduction, and pain relief to patients undergoing painful procedures in a physician's office. AcelRx Pharmaceuticals, Inc. is headquartered in Redwood City, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $73.383B 41.65
Takeda Pharmaceutical (TAK) Japan $58.389B 10.18
Astellas Pharma (ALPMY) Japan $30.180B 15.29
UCB SA (UCBJF) Belgium $24.702B 0.00
Eisai (ESALY) Japan $24.615B 21.34
Merck (MKGAF) Germany $17.008B 22.31
Catalent (CTLT) United States $13.967B 53.99
Grifols, S.A (GRFS) Spain $13.118B 16.03
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.669B 0.00
Neurocrine Biosciences (NBIX) United States $11.423B 44.41
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Ionis Pharmaceuticals (IONS) United States $8.246B 43.84
Orion OYJ (ORINY) Finland $7.077B 24.56
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.906B 0.00
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.195B 9.91
United Therapeutics (UTHR) United States $5.170B 11.95
Arrowhead Pharmaceuticals (ARWR) United States $4.517B 493.11
Hypermarcas (HYPMY) Brazil $4.293B 15.79
Evotec AG (EVTCY) Germany $4.065B 109.55
Nektar Therapeutics (NKTR) United States $3.930B 0.00
FibroGen (FGEN) United States $3.780B 0.00
ChemoCentryx (CCXI) United States $3.385B 0.00
PTC Therapeutics (PTCT) United States $3.121B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.504B 12.12
Sage Therapeutics (SAGE) United States $2.410B 0.00
Cronos Group (CRON) Canada $2.376B 67.90
Pacira BioSciences (PCRX) United States $2.312B 47.32
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.820B 0.00
Xencor (XNCR) United States $1.814B 0.00
Corcept Therapeutics (CORT) United States $1.759B 17.44
USANA Health Sciences (USNA) United States $1.706B 16.08
Indivior (INVVY) United States $1.655B 20.55
Ironwood Pharmaceuticals (IRWD) United States $1.567B 11.99
Heron Therapeutics (HRTX) United States $1.521B 0.00
Akebia Therapeutics (AKBA) United States $1.510B 0.00
Revolution Medicines (RVMD) United States $1.433B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.410B 15.19
Zogenix (ZGNX) United States $1.348B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.256B 0.00
Karyopharm Therapeutics (KPTI) United States $1.233B 0.00
Esperion Therapeutics (ESPR) United States $1.116B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.102B 0.00
VAXART, INC (VXRT) United States $1.009B 0.00
Translate Bio (TBIO) United States $0.988B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.941B 42.01
Tilray (TLRY) Canada $0.928B 0.00
Altimmune (ALT) United States $0.872B 0.00
Endo (ENDP) Ireland $0.832B 1.29
BioCryst Pharmaceuticals (BCRX) United States $0.776B 0.00
ImmunoGen (IMGN) United States $0.726B 0.00
Trillium Therapeutics (TRIL) Canada $0.620B 0.00
Collegium Pharmaceutical (COLL) United States $0.572B 0.00
Radius Health (RDUS) United States $0.566B 0.00
Aerie Pharmaceuticals (AERI) United States $0.552B 0.00
Siga Technologies (SIGA) United States $0.528B 0.00
Ardelyx (ARDX) United States $0.527B 0.00
Molecular Templates (MTEM) United States $0.526B 0.00
Flexion Therapeutics (FLXN) United States $0.523B 0.00
TherapeuticsMD (TXMD) United States $0.516B 0.00
Innate Pharma SA (IPHYF) France $0.495B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.492B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.472B 18.43
Crinetics Pharmaceuticals (CRNX) United States $0.462B 0.00
DURECT (DRRX) United States $0.460B 0.00
Ocular Therapeutix (OCUL) United States $0.448B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.427B 10.32
Rigel Pharmaceuticals (RIGL) United States $0.410B 0.00
Organogenesis Holdings (ORGO) United States $0.394B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.368B 0.00
Calithera Biosciences (CALA) United States $0.343B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.316B 0.00
IMV INC (IMV) Canada $0.313B 0.00
PROFOUND MEDICL (PROF) Canada $0.304B 0.00
MEI Pharma (MEIP) United States $0.302B 0.00
Harpoon Therapeutics (HARP) United States $0.301B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.284B 0.00
Concert Pharmaceuticals (CNCE) United States $0.282B 0.00
Redhill Biopharma (RDHL) Israel $0.275B 0.00
OptiNose (OPTN) United States $0.262B 0.00
Lannett Co Inc (LCI) United States $0.253B 5.54
CASI Pharmaceuticals (CASI) United States $0.235B 0.00
Rafael Holdings (RFL) United States $0.227B 0.00
Nature's Sunshine Products (NATR) United States $0.202B 26.61
Taiwan Liposome (TLC) Taiwan $0.198B 0.00
KalVista Pharmaceuticals (KALV) United States $0.195B 0.00
Nivalis Therapeutics (ALPN) United States $0.195B 0.00
Onconova Therapeutics (ONTX) United States $0.192B 0.00
Aquestive Therapeutics (AQST) United States $0.191B 0.00
Heat Biologics (HTBX) United States $0.176B 0.00
Jounce Therapeutics (JNCE) United States $0.163B 3.89
Matinas Biopharma Holdings (MTNB) United States $0.161B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.130B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.121B 0.00
Xeris Pharmaceuticals (XERS) United States $0.116B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.111B 0.00
CTI BioPharma (CTIC) United States $0.109B 0.00
Biomerica (BMRA) United States $0.109B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.109B 0.00
Champions Oncology (CSBR) United States $0.108B 0.00
Otonomy (OTIC) United States $0.105B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.105B 0.00
MediWound (MDWD) Israel $0.105B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.102B 0.00
Recro Pharma (REPH) United States $0.097B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.096B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.093B 0.00
Hemispherx BioPharma (AIM) United States $0.092B 0.00
Aclaris Therapeutics (ACRS) United States $0.089B 0.00
ElectroCore (ECOR) United States $0.089B 0.00
Lipocine (LPCN) United States $0.082B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.071B 0.00
SCYNEXIS (SCYX) United States $0.069B 0.00
CV Sciences (CVSI) United States $0.066B 0.00
Sundial Growers (SNDL) Canada $0.063B 0.00
PolarityTE (PTE) United States $0.062B 0.00
Infinity Pharmaceuticals (INFI) United States $0.054B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 30.90
Addex Therapeutics (ADXN) Switzerland $0.051B 0.00
Novan (NOVN) United States $0.049B 0.00
IsoRay (ISR) United States $0.045B 0.00
Natural Alternatives (NAII) United States $0.045B 0.00
GTx (ONCT) United States $0.044B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Mannatechorporated (MTEX) United States $0.042B 7.92
AgeX Therapeutics (AGE) United States $0.041B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.041B 0.00
Jaguar Animal Health (JAGX) United States $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 83.18
NovaBay Pharmaceuticals (NBY) United States $0.038B 0.00
Can-Fite Biopharma (CANF) Israel $0.038B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.036B 0.00
Neos Therapeutics (NEOS) United States $0.033B 0.00
India Globalization Capital (IGC) United States $0.030B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.028B 0.00
ProPhase Labs (PRPH) United States $0.020B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.018B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
RXi Pharmaceuticals (PHIO) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 34.29
Regulus Therapeutics (RGLS) United States $0.014B 0.00
China SXT Pharmaceuticals (SXTC) China $0.014B 0.00
Shineco (TYHT) China $0.013B 0.00
Midatech Pharma (MTP) United Kingdom $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
Vical (BBI) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00